EUVIMEDEUVIMED entdecken
Open Access

α-Tocopherol reduces VLDL secretion through modulation of intracellular ER-to-Golgi transport of VLDL

Ryan Clay iD, Shaila Siddiqi, Shadab A Siddiqi iD

Canadian Journal of Physiology and Pharmacology · 2023

DOI: 10.1139/cjpp-2023-0086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Journal of Physiology and Pharmacology, 2023. Verfasst von Ryan Clay und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Metabolic and Cardiovascular Sciences, Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando…. Hauptthemen laut MEDLINE: Lipoproteins, VLDL, Fatty Liver. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Avoiding hepatic steatosis is crucial for preventing liver dysfunction, and one mechanism by which this is accomplished is through synchronization of the rate of very low density lipoprotein (VLDL) synthesis with its secretion. Endoplasmic reticulum (ER)-to-Golgi transport of nascent VLDL is the rate-limiting step in its secretion and is mediated by the VLDL transport vesicle (VTV). Recent in vivo studies have indicated that α-tocopherol (α-T) supplementation can reverse steatosis in nonalcoholic fatty liver disease, but its effects on hepatic lipoprotein metabolism are poorly understood. Here, we investigated the impact of α-T on hepatic VLDL synthesis, secretion, and intracellular ER-to-Golgi VLDL trafficking using an in vitro model. Pulse-chase assays using [ 3 H]-oleic acid and 100 µmol/L α-T demonstrated a disruption of early VLDL synthesis, resulting in enhanced apolipoprotein B-100 expression, decreased expression in markers for VTV budding, ER-to-Golgi VLDL transport, and reduced VLDL secretion. Additionally, an in vitro VTV budding assay indicated a significant decrease in VTV production and VTV–Golgi fusion. Confocal imaging of lipid droplet (LD) localization revealed a decrease in overall LD retention, diminished presence of ER-associated LDs, and an increase in Golgi-level LD retention. We conclude that α-T disrupts ER-to-Golgi VLDL transport by modulating the expression of specific proteins and thus reduces VLDL secretion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipoproteins, VLDLFatty LiverHumansalpha-TocopherolLiverTransport VesiclesEndoplasmic ReticulumTriglycerides

Stichwörter der Autor:innen

ER-to-Golgi traffickingVLDL secretionVLDL transport vesicle (VTV)triacylglycerolvery low density lipoprotein (VLDL)α-tocopherol

Substanzen

Lipoproteins, VLDLalpha-TocopherolTriglycerides

Autor:innen und Institutionen

  • Division of Metabolic and Cardiovascular Sciences, Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL 32827, USA.

ORCID-Profile: Ryan Clay, Shadab A Siddiqi

Förderung

  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institutes of Health

Zitieren

APA

Clay, R., Siddiqi, S., & Siddiqi, S. A. (2023). α-Tocopherol reduces VLDL secretion through modulation of intracellular ER-to-Golgi transport of VLDL. Canadian Journal of Physiology and Pharmacology. https://doi.org/10.1139/cjpp-2023-0086

Vancouver

Clay R, Siddiqi S, Siddiqi SA. α-Tocopherol reduces VLDL secretion through modulation of intracellular ER-to-Golgi transport of VLDL. Canadian Journal of Physiology and Pharmacology. 2023. doi:10.1139/cjpp-2023-0086

BibTeX
@article{Clay2023,
  author = {Clay, Ryan and Siddiqi, Shaila and Siddiqi, Shadab A},
  title = {α-Tocopherol reduces VLDL secretion through modulation of intracellular ER-to-Golgi transport of VLDL},
  journal = {Canadian Journal of Physiology and Pharmacology},
  year = {2023},
  doi = {10.1139/cjpp-2023-0086}
}
Kostenlos starten →